Long-term follow-up of a young male who developed acute macular neuroretinopathy following COVID-19 vaccination.
Clin Case Rep
; 11(11): e8181, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-38028086
ABSTRACT
This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID-19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Case Rep
Ano de publicação:
2023
Tipo de documento:
Article